230 related articles for article (PubMed ID: 28195903)
1. Muscle Involvement of Multiple Myeloma Revealed by FDG PET/CT.
Liang M; Su M; Wang R; Wang W; Fan C
Clin Nucl Med; 2017 Apr; 42(4):300-302. PubMed ID: 28195903
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Whole-Body DWI and
Chen J; Li C; Tian Y; Xiao Q; Deng M; Hu H; Wen B; He Y
AJR Am J Roentgenol; 2019 Sep; 213(3):514-523. PubMed ID: 31166755
[No Abstract] [Full Text] [Related]
3. Role of
Cavo M; Terpos E; Nanni C; Moreau P; Lentzsch S; Zweegman S; Hillengass J; Engelhardt M; Usmani SZ; Vesole DH; San-Miguel J; Kumar SK; Richardson PG; Mikhael JR; da Costa FL; Dimopoulos MA; Zingaretti C; Abildgaard N; Goldschmidt H; Orlowski RZ; Chng WJ; Einsele H; Lonial S; Barlogie B; Anderson KC; Rajkumar SV; Durie BGM; Zamagni E
Lancet Oncol; 2017 Apr; 18(4):e206-e217. PubMed ID: 28368259
[TBL] [Abstract][Full Text] [Related]
4. Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma.
Caldarella C; Annunziata S; Pagano L; De Stefano V; Rufini V
Clin Nucl Med; 2017 Feb; 42(2):e130-e134. PubMed ID: 27922862
[TBL] [Abstract][Full Text] [Related]
5. FDG PET-CT in Adrenal Multiple Myeloma.
Choudhury S; Purandare N; Agrawal A; Shah S; Rangarajan V
Clin Nucl Med; 2018 Sep; 43(9):691-692. PubMed ID: 30015660
[TBL] [Abstract][Full Text] [Related]
6. Fluorodeoxyglucose-PET/Computed Tomography as a Predictor of Prognosis in Multiple Myeloma.
Nanni C; Zamagni E
PET Clin; 2019 Jul; 14(3):383-389. PubMed ID: 31084777
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone.
Nanni C; Rubello D; Zamagni E; Castellucci P; Ambrosini V; Montini G; Cavo M; Lodi F; Pettinato C; Grassetto G; Franchi R; Gross MD; Fanti S
In Vivo; 2008; 22(4):513-7. PubMed ID: 18712181
[TBL] [Abstract][Full Text] [Related]
8. Rare Extramedullary Cardiac Involvement of Recurrent Multiple Myeloma Suspected on 18F-FDG and Confirmed on 18F-Fluorocholine.
Zhang-Yin J; Garderet L; Martino S; Montravers F; Talbot JN
Clin Nucl Med; 2020 Nov; 45(11):916-918. PubMed ID: 32796239
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG and 18F-NaF PET/CT Findings of a Multiple Myeloma Patient With Thyroid Cartilage Involvement.
Oral A; Yazici B; Ömür Ö; Comert M; Saydam G
Clin Nucl Med; 2015 Nov; 40(11):873-6. PubMed ID: 26204214
[TBL] [Abstract][Full Text] [Related]
10. Extramedullary Myeloma of the Uterus on 18F-FDG PET/CT: A Rare Manifestation of Multiple Myeloma.
Causa Andrieu PI; Das JP; Woo S; Ryan R; Akin O; Ulaner GA
Clin Nucl Med; 2020 Nov; 45(11):873-875. PubMed ID: 32657873
[TBL] [Abstract][Full Text] [Related]
11. Whole-body (18)F-FDG PET identifies high-risk myeloma.
Durie BG; Waxman AD; D'Agnolo A; Williams CM
J Nucl Med; 2002 Nov; 43(11):1457-63. PubMed ID: 12411548
[TBL] [Abstract][Full Text] [Related]
12. PET with Fluorodeoxyglucose F 18/Computed Tomography as a Staging Tool in Multiple Myeloma.
Seval GC; Ozkan E; Beksac M
PET Clin; 2019 Jul; 14(3):369-381. PubMed ID: 31084776
[TBL] [Abstract][Full Text] [Related]
13. A Rare Extramedullary Involvement Site in Patients With Multiple Myeloma: Stomach.
Gülbahar Ateş S; Uçmak G
Clin Nucl Med; 2022 Nov; 47(11):e702-e703. PubMed ID: 35619203
[TBL] [Abstract][Full Text] [Related]
14. Is fluorine-18-fluorocholine PET/CT suitable for the detection of skeletal involvement of multiple myeloma?
Meckova Z; Lambert L; Spicka I; Kubinyi J; Burgetova A
Hell J Nucl Med; 2018; 21(3):167-168. PubMed ID: 30411725
[TBL] [Abstract][Full Text] [Related]
15. Is there any complimentary role of F-18 NaF PET/CT in detecting of osseous involvement of multiple myeloma? A comparative study for F-18 FDG PET/CT and F-18 FDG NaF PET/CT.
Ak İ; Onner H; Akay OM
Ann Hematol; 2015 Sep; 94(9):1567-75. PubMed ID: 26068066
[TBL] [Abstract][Full Text] [Related]
16. Role of FDG PET in the staging of multiple myeloma.
Vicentini JRT; Bredella MA
Skeletal Radiol; 2022 Jan; 51(1):31-41. PubMed ID: 33813607
[No Abstract] [Full Text] [Related]
17. Neuro-Myelomatosis of the Brachial Plexus - An Unusual Site of Disease Visualized by FDG-PET/CT: A Case Report.
Fukunaga H; Mutoh T; Tatewaki Y; Shimomura H; Totsune T; Terao C; Miyazawa H; Taki Y
Am J Case Rep; 2017 May; 18():478-481. PubMed ID: 28458390
[TBL] [Abstract][Full Text] [Related]
18. Comparison of (11)C-4'-thiothymidine, (11)C-methionine, and (18)F-FDG PET/CT for the detection of active lesions of multiple myeloma.
Okasaki M; Kubota K; Minamimoto R; Miyata Y; Morooka M; Ito K; Ishiwata K; Toyohara J; Inoue T; Hirai R; Hagiwara S; Miwa A
Ann Nucl Med; 2015 Apr; 29(3):224-32. PubMed ID: 25421383
[TBL] [Abstract][Full Text] [Related]
19. Whole-body 18F-FDG PET/CT in patients with multiple myeloma.
de Bonilla Damiá A; Fernández López R; Paz Coll A; Borrego Dorado I
Med Clin (Barc); 2017 Apr; 148(7):e37. PubMed ID: 27450173
[No Abstract] [Full Text] [Related]
20. Multiple Myeloma Presenting as Disseminated Osteoblastic Lesions With Intense 18F-FDG Uptake on PET/CT.
Wang Y; Fan Q; Su M
Clin Nucl Med; 2021 Oct; 46(10):e492-e495. PubMed ID: 33630796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
